Immune balance restored

A new approach to autoimmunity: Checkpoint agonist antibodies



MiroBio’s unique approach to restore balance to the immune system is reminiscent of the kintsugi technique which unites pottery pieces to create new function and beauty




As of Sept. 20, 2022, we have joined Gilead to advance our shared goal of developing breakthrough therapies for people living with unmet medical needs in inflammation.


Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, inflammation and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.  For more information, please visit

MiroBio_Web_Hero_09 18 21-homethumbnail

We’re learning the language of immune cells to control their activity

We are exclusively focused on precise control of inhibitory signaling to restore balanced immune activity – and health.

We are mastering a vast new landscape of inhibitor receptors

In continual conversation with each other and stimulatory receptors across many cell types, these receptors are at the heart of immune checkpoints and create a dynamic environment that is ready for exploration and translation into new medicines.

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser